By Associate Professor Handan Cetin Wand

Journal articles

Carey DL; Wand HC; Martin A; Rothwell S; Emery S; Cooper DA; Carr AD, 2005, 'Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial', AIDS, 19, pp. 1325 - 1327

Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2005, 'Increase in limb fat after nucleoside analogue cessation is not associated with decreased visceral fat and has different risk factors', Antiviral Therapy, 10, pp. L5 - L5

Kovacic JC; Martin A; Carey DL; Wand HC; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr AD, 2005, 'Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy', Antiviral Therapy, 10, pp. 135 - 143

Cavalcanti RB; Raboud J; Kain KC; Walmsley S; Carr A; Wand H, 2004, 'Rosiglitazone for HIV-1 lipoatrophy [3] (multiple letters)', Lancet, 363, pp. 1828 - 1829, http://dx.doi.org/10.1016/S0140-6736(04)16318-6

Carr A; Workman C; Carey D; Rogers G; Martin A; Baker D; Wand H; Law M; Samaras K; Emery S; Cooper DA, 2004, 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: Randomised, double-blind, placebo-controlled trial', Lancet, 363, pp. 429 - 438, http://dx.doi.org/10.1016/S0140-6736(04)15489-5

Martin A; Smith D; Carr A; Hoy J; Chuah J; Mallal S; Law M; Clements M; Cooper DA; Macrae K; James R; Mijch A; McCormack C; Baker D; McLeod H; Kidd J; McFarlane R; Vale R; Roth N; Wood H; Finlayson R; Bodsworth N; Wheatley D; Austin D; Bloch M; Frater A; Doong N; Hudson J; Anderson J; Patching J; Leung J; Lee W; Sharkey T; Wand H, 2004, 'Progression of lipodystrophy (LD) with continued thymidine analogue usage: Long-term follow-up from a randomized clinical trial (the PIILR study)', HIV Clinical Trials, 5, pp. 192 - 200, http://dx.doi.org/10.1310/0GU7-6X27-MMHE-5ALE

Joshipura KJ; Wand HC; Merchant AT; Rimm EB, 2004, 'Periodontal disease and biomarkers related to cardiovascular disease', Journal of Dental Research, 83, pp. 151 - 155, http://dx.doi.org/10.1177/154405910408300213

Carey DL; Workman C; Rogers GJ; Baker DA; Martin A; Wand HC; Emery S; Cooper DA; Carr AD, 2004, 'Rosiglitazone for HIV lipoatrophy: 84 weeks follow-up', Antiviral Therapy, 9, pp. L46 - L46

Carr AD; Wand HC, 2004, 'Rosiglitazone for HIV-1 Lipoatrophy', The Lancet, 363, pp. 1829 - 1829, http://dx.doi.org/10.1016/S0140-6736(04)16319-8

Carr AD; Wand HC, 2004, 'Rosiglitazone for HIV-1 lipoatrophy - Reply', Lancet, 363, pp. 1829 - 1829

Mallon PW; Wand HC; Law MG; Miller JM; Cooper DA; Carr AD, 2003, 'Strong association between buffalo hump and high serum insulin concentrations in HIV-infected individuals', Antiviral Therapy, 8, pp. L61 - L61

Rich-Edwards JW; Spiegelman D; Garland M; Hertzmark E; Hunter DJ; Colditz GA; Willett WC; Wand H; Manson JAE, 2002, 'Physical activity, body mass index, and ovulatory disorder infertility', Epidemiology, 13, pp. 184 - 190, http://dx.doi.org/10.1097/00001648-200203000-00013

WAND HC; FEDOROFF S; DICKINSO C, 1972, 'FACTORS AFFECTING QUALITY OF G BANDS PRODUCED BY TRYPSIN IN HUMAN CHROMOSOMES', CYTOBIOS, 6, pp. 47 - 54

WAND H; BACIGALUPO G, 1966, 'INFLUENCE OF ETHANOL ON ISOLATED MITOCHONDRIA', BIOCHEMICAL PHARMACOLOGY, 15, pp. 1491 - +, http://dx.doi.org/10.1016/0006-2952(66)90194-8

Back to profile page